Trials / Completed
CompletedNCT06612346
Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (actual)
- Sponsor
- Sanoculis Ltd · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Minimally Invasive Micro Trabeculostomy | The MINT system is a surgical device designed to create a trabeculostomy within the eye. |
Timeline
- Start date
- 2022-11-04
- Primary completion
- 2024-10-22
- Completion
- 2024-12-31
- First posted
- 2024-09-25
- Last updated
- 2025-01-10
Locations
1 site across 1 country: Armenia
Source: ClinicalTrials.gov record NCT06612346. Inclusion in this directory is not an endorsement.